High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 438-441

  Bouyou Akotet, Marielle Karine ^a   Mawili Mboumba, Denise Patricia ^a   de Dieu Tchantchou, Tanguy ^a   Kombila, Maryvonne ^a  

^a UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

Author keywords

Drug resistance; Malaria; Pregnancy

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GABON; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MUTATIONAL ANALYSIS; NONHUMAN; PARASITE ISOLATION; PLACENTA; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PROPHYLAXIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; ANTIMALARIALS; BLOOD; DIHYDROPTEROATE SYNTHASE; DNA RESTRICTION ENZYMES; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; GABON; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MUTATION, MISSENSE; PLACENTA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 77950307520     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp467     Document Type: Article

References (16)

1. Aubouy A, Jafari S, Huart V et al. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 2003; 52: 43-9.
2. Nsimba B, Guiyedi V, Mabika-Mamfoumbi M et al. Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy. Malar J 2008; 7: 31.
3. Tinto H, Ouédraogo JB, Zongo I et al. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg 2007; 76: 608-13.
4. Eriksen J, Mwankusye S, Mduma S et al. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania. Trans R Soc Trop Med Hyg 2008; 102: 137-42.
5. Bouyou-Akotet MK, Nzenze-Afene S, Ngoungou EB et al. Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon. Am J Trop Med Hyg 2009; in press.
6. Planche T, Krishna S, Kombila M et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65: 599-602.
7. Duraisingh MT, Curtis J, Warhurst DC. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 1998; 89:1-8.
8. Kun JF, Lehman LG, Lell B et al. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother 1999; 43: 2205-8.
9. Mockenhaupt FP, Bedu-Addo G, Eggelte TA et al. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis 2008; 198: 1545-9.
10. Mockenhaupt FP, Bedu-Addo G, Junge C et al. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob Agents Chemother 2007; 51: 332-4.
11. Noranate N, Durand R, Tall A et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One 2007; 2: e139.
12. Picot S, Olliaro P, de Monbrison F et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J 2009; 8: 89.
13. Menéndez C, Bardají A, Sigauque B et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008; 3: e1934.
14. Briand V, Denoeud L, Massougbodji A et al. Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin. J Infect Dis 2008; 198: 594-601.
15. Briand V, Bottero J, NoëlHet al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis 2009; 200: 991-1001.
16. Clerk CA, Bruce J, Affipunguh PK et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis 2008; 198: 1202-11.